
First-Time Alcohol Diagnoses Rose 36% in a Decade. The Share of Adults Who Say They Drink Fell to 54%.
The report that Epic Research published on Nov. 19 reads at first like a verdict on American drinking. Among 196,522,676 adults whose records sit in the company's Cosmos data set, the annual rate of a first alcohol use disorder diagnosis climbed 36.3 percent between 2016 and 2025 — from 543.1 per 100,000 adults to 740.5. First diagnoses of alcohol-associated liver disease rose 20.6 percent over the same years, from 80.2 to 96.7.
Then comes the number that sits awkwardly beside it, drawn from federal survey data in the same report: the share of U.S. adults who said they had drunk alcohol recently fell to 54 percent in 2025, down from 62 percent in 2023.
Both figures can be right at once, because they are not counting the same population or the same event. One counts people who told a survey they drank. The other counts people whose doctor wrote a code into their chart for the first time. The distance between those two things is where the decade's real story sits, and it is mostly a story about measurement, not thirst.
A diagnosis rate counts encounters, not drinking
Epic built the analysis from Cosmos, a pooled record set the company says covers more than 300 million patients across 2,200 hospitals and 50,000-plus clinics in all 50 states. For this study the researchers restricted the sample to U.S. adults who were active patients in a given year, then counted only the first qualifying diagnosis per person between 2016 and 2025. Alcohol use disorder was identified through ICD-10-CM code F10, excluding remission codes; alcohol-associated liver disease through K70.0 through K70.4.
That construction sets the boundaries of what the numbers can mean. The numerator is a coding event, not the moment a person's drinking became a problem. The denominator is adults who sought care, not the adult public. And the rates are crude — not age-standardized — so a patient panel that got older over ten years will generate more diagnoses of a condition that tracks with age, without anyone drinking more than before.
Epic says as much in the report, listing increased screening, denser coding and shifts in health care use among the plausible explanations, alongside a genuine rise in disease.
The 2023 step has a paper trail
The shape of the alcohol use disorder curve is the most interesting thing in the report. From 2016 through 2022 the annual first-diagnosis rate barely moved: 543.1 to 577.2 per 100,000 over six years, a rise of 6.3 percent. Then, in 2023 alone, it jumped 20.2 percent, from 577.2 to 693.6. Over the two years that followed it added another 6.8 percent.
That is not how a behavioral trend usually looks. It is, however, how a coding change looks. Revisions to the ICD-10-CM codes for alcohol-related conditions took effect on Oct. 1, 2022, and Epic's authors state plainly that part of the 2023 increase may reflect the new codes rather than a change in underlying incidence.
The arithmetic sharpens the point. Strip out the single year in which the classification changed and the residual growth — 693.6 to 740.5 per 100,000 between 2023 and 2025, up 6.8 percent — is still larger than the entire six-year movement that preceded it. Whatever the code revision did, it did not produce all of the rise. Something else was already pushing diagnoses upward, and kept pushing after the new codes were in place.
Women closed part of a very wide gap
Men carried more than twice the diagnosis rate of women in every year of the study, for both conditions. That did not change. What changed was the slope.
New alcohol use disorder diagnoses rose 42.6 percent among women against 30.0 percent among men. For alcohol-associated liver disease the split is wider still: 29.2 percent among women, 13.3 percent among men. In absolute terms the ranking reverses — men added 250.2 diagnoses per 100,000 adults over the decade, women 145.4 — because men started from a rate more than twice as high.
Two facts, then, that are easy to flatten into one headline. Relative growth in first alcohol diagnoses over the past decade was fastest among women. The bulk of the clinical burden still sits with men, by a margin that has narrowed but not closed.
The generations moved in opposite directions
Alcohol use disorder diagnoses increased in every generation Epic examined. The Silent Generation, born 1928 to 1945, posted the steepest relative rise at 54.3 percent, followed by Baby Boomers at 32.3 percent, with Generation X and Millennials each up roughly 30 percent. Generation Z showed 56.6 percent growth, though the report notes that cohort started from a low base and was only beginning to reach adulthood during the study window.
Liver disease refused to follow the same pattern. Diagnoses climbed sharply among Generation X and Millennials and stayed flat or drifted down among the oldest groups — the reverse of what a simple "everyone is drinking more" story would predict, and a useful reminder that the two conditions run on different clocks.
Why the liver series lags
Alcohol-associated liver disease develops over years, often silently, before anyone codes it. A first diagnosis therefore records the moment a clinician noticed, not the moment the damage began. Epic's authors point out that older age is an established risk factor for the condition, so part of the increase among younger and middle-aged adults may reflect people simply aging into their higher-risk years across a decade. Generation Z's liver disease rate went from 1.3 per 100,000 in 2017 to 16.2 in 2025 — a twelvefold rise from a base so small that the condition remains uncommon in that group.
The denominator, and the 27.9 million it never reaches
Every rate in this report is per 100,000 adults who were active patients that year. Change the pool of people who show up for care and the rate moves without a single additional drink being poured.
The decade covered by the study included a pandemic that pushed millions into telehealth, a sustained national push to screen for unhealthy alcohol use in primary care, and a visible contraction in some rural hospital networks that left fewer places to be seen. Each of those forces reshapes who lands in the denominator, and in which year. None of them appears in a chart of diagnosis rates, and all of them can bend the line.
Then there is the population the denominator never captures at all. Epic's report puts the estimated number of Americans living with alcohol use disorder at 27.9 million — roughly one in nine adults. Set that against the diagnosis rate: 740.5 first diagnoses per 100,000 adults works out to about three-quarters of one percent of the adult population in a year.
The comparison is crude, and it mixes a prevalence estimate from survey research with an incidence figure from electronic records. It still says something no single-year number can. Most people living with the disorder are not being newly diagnosed in any given year, which means the diagnosis stream measures access and ascertainment as much as it measures illness. The gap between 27.9 million and the annual trickle of new codes is the treatment gap expressed as arithmetic.
The same report notes, citing earlier published work, that alcohol-associated liver disease deaths roughly doubled between 1999 and 2022. Deaths are harder to code your way out of than diagnoses.
What a clinic should take from a coding-heavy curve
For clinicians, the operational reading is unglamorous. A thickening stream of first alcohol use disorder diagnoses is good news if, and only if, the capacity to treat arrives with it. Screening that identifies a disorder nobody can get into care for is a measurement exercise with a body count attached.
That matters more than usual here, because alcohol use disorder has three FDA-approved medications — naltrexone, acamprosate and disulfiram — that remain among the least-used evidence-based options in addiction medicine, and medication-assisted treatment for alcohol dependence is still frequently framed as something that happens after everything else fails. A rising diagnosis rate is the cheapest possible moment to prescribe.
What survived the caveats
Epic says two independent teams, each pairing a clinician with a research scientist, completed the analysis and reached similar conclusions — an internal check against one analyst's coding choices driving the result.
The caveats are real and the report states them: crude rates, a care-seeking denominator, diagnoses that record documentation rather than onset, and a 2023 inflection that owes something to a code revision. Take all of that away and one finding still stands on its own. From 2023 through 2025, after the new codes were in force and after the initial step had been absorbed, first alcohol use disorder diagnoses kept climbing at a rate faster than the six years before the change combined.
The surveys say fewer adults are drinking. The charts say more of them are being diagnosed. A treatment system that reads only one of those sentences will get the next decade wrong.
Sources
- Epic Research, "Alcohol Use Disorder and Alcohol-Associated Liver Disease Diagnoses Rose 36% and 21% Over the Past Decade," Nov. 19, 2026
- Vinetur, "New U.S. alcohol use disorder diagnoses rose 36.3% between 2016 and 2025," Nov. 20, 2026
- Substance Abuse and Mental Health Services Administration, Medications for Substance Use Disorders — regulatory guidance
Editorial Board
LADC, LCPC, CASAC
The Rainier Rehab editorial team consists of licensed addiction counselors, healthcare journalists, and recovery advocates dedicated to providing accurate, evidence-based information about substance abuse treatment and rehabilitation.
Related Articles

Seventy Percent of Patients Get Asked About Drinking. Four Percent of Heavy Drinkers Get Told to Cut Back.
A national NSDUH analysis finds 69% of US adults are screened for alcohol use, but only 4% of heavy drinkers get a brief intervention, and women fare worse.

Drug-Linked Heart Infections Fell 18 Percent. Stimulants Now Drive Nearly Half of Them.
A national study of 118,190 hospitalizations finds drug use-associated endocarditis declining since 2020, while stimulants' share climbed from 37 to 47 percent.

One in Nine Older Adults Who Use Cannabis Meet Criteria for a Disorder. Nobody Is Screening Them.
A UC San Diego study of 21,189 adults over 65 finds 11.4% of past-year cannabis users meet criteria for cannabis use disorder. Clinicians rarely ask.